Drug survival time on anti-TNF agents: Does prior anti-TNF use influence RA outcomes?

被引：0
|
作者：
Kishimoto, M
Greenberg, J
Abramson, SB
Harrington, T
Olenginski, TP
Kafka, SP
Reed, G
Hinkle, K
Kremer, J
Cohen, SB
机构：
[1] NYU, Hosp Joint Dis, New York, NY USA
[2] Geisinger Med Ctr, Danville, PA USA
[3] Clin Res Ctr, Duncansville, PA USA
[4] Univ Massachusetts, Worcester, MA 01605 USA
[5] Ctr Rheumatol, Albany, NY USA
[6] Radiant Res Dallas, Dallas, TX USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [21] THE SAFETY OF ANTI-TNF AGENTS IN THE ELDERLY
    Migliore, A.
    Bizzi, E.
    Lagana, B.
    Altomonte, L.
    Zaccari, G.
    Granata, M.
    Canzoni, M.
    Marasini, B.
    Massarotti, M.
    Massafra, U.
    Ranieri, M.
    Pilla, R.
    Martin, L. S.
    Pezza, M.
    Vacca, F.
    Galluccio, A.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 415 - 426
  • [22] An audit of the use of anti-TNFα agents in ankylosing spondylitis( AS)
    Trebilcock, Emily
    Rankin, Elizabeth
    RHEUMATOLOGY, 2008, 47 : II65 - II65
  • [23] Does failure to respond to one anti-TNF agent in Ulcerative Colitis predict treatment failure with other anti-TNF agents?
    AlAlawi, F.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S254 - S254
  • [24] Does Failure to Respond to One Anti-TNF Agent in Ulcerative Colitis Predict Treatment Failure With Other Anti-TNF Agents
    AlAlawi, Fatema
    Keegan, Denise
    Byrne, Kathryn
    Mulcahy, Hugh
    Cullen, Garret
    Doherty, Glen A.
    GASTROENTEROLOGY, 2015, 148 (04) : S266 - S267
  • [25] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [26] To Determine the Relationship Between Time of Anti-TNFα Therapy Initiation and Anti-TNFα Dose Escalation
    Lam, Mindy Ching Wan
    Atkinson, Kenneth
    Bressler, Brian
    GASTROENTEROLOGY, 2011, 140 (05) : S280 - S280
  • [27] COMPARISON OF DRUG DISCONTINUATION TO INEFFICACY AND ADVERSE EVENTS BETWEEN ANTI-TNF AGENTS AND 'NON-ANTI-TNF BIOLOGIC AGENTS' IN ANTI-TNF INADEQUATE RESPONDER RHEUMATOID ARTHRITIS PATIENTS
    Martin-du-Pan, S.
    Neto, D.
    Zufferey, P.
    Ciurea, A.
    Ziswiler, H.
    Gabay, C.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 615 - 615
  • [28] Failing a First Anti-TNF in RA: Does it Imply a Change in Target?
    Finckh, Axel
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (01) : 88 - 93
  • [29] Tracking TNF and anti-TNF agents in inflamed gut tissue
    Katrina Ray
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 (4) : 189 - 189
  • [30] Anti-TNF alpha
    Faure, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2010, 49 (500): : 51 - 54
12345